In contrast, a recent study showed that systemic administration of GANT61, an inhibitor of Gli1 and Gli2 [42], to rats resulted in smaller NP area and IVD height with minimal effects on the AF compartment [19]. This evidence concerns the gene GLI2 and atrial fibrillation.